Yaron Daniely
Directeur Général chez Yissum Research Development Co. Ltd.
Profil
Yaron Daniely is currently the President & Chief Executive Officer at Yissum Research Development Co. Ltd.
and a Member at the American Society of Hematology.
He is also a General Partner at aMoon Ventures Y Sh Ltd.
Dr. Daniely previously served as the President & CEO of Starlet Derma Ltd.
and NanoCyte Ltd.
He was also a Director at Alcobra Ltd., Bioblast Pharma Ltd., and Integra Holdings Ltd.
Additionally, he was a Member of the National Institutes of Health and the Weizmann Institute of Science.
Dr. Daniely started his career as the Vice President-Business Development at Gamida Cell Ltd.
He holds an undergraduate degree from Florida International University, an MBA from Technion-Israel Institute of Technology, and a doctorate from New York University School of Medicine.
Postes actifs de Yaron Daniely
| Sociétés | Poste | Début |
|---|---|---|
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Directeur Général | - |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Private Equity Investor | 01/11/2019 |
Anciens postes connus de Yaron Daniely
| Sociétés | Poste | Fin |
|---|---|---|
Starlet Derma Ltd.
 Starlet Derma Ltd. Pharmaceuticals: MajorHealth Technology Starlet Derma Ltd. develops a novel marine extracted microinjection system for Intra-dermal penetration. It provides its services through its wholly owned subsidiary, NanoCyte Ltd. The firm's products are used for various cosmeceutical applications, such as acne treatments, whitening, pain relief, anti-aging treatments, and slimming treatments. The company was founded by Shimon Eckhouse, Chen Porat, and Amid Lotan in 2000 and is headquartered in Caesarea, Israel. | Directeur Général | 01/05/2010 |
NanoCyte Ltd.
 NanoCyte Ltd. Pharmaceuticals: MajorHealth Technology NanoCyte Ltd. develops transdermal drug delivery platform technology solutions. The firm offers cosmeceutical and pharmaceutical applications such as whitening, acne, anti-aging, and slimming treatment. The company was founded by Shimon Eckhouse and is headquartered in Zemach, Israel. | Directeur Général | 02/01/2010 |
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Directeur/Membre du Conseil | - |
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | - |
Formation de Yaron Daniely
| Florida International University | Undergraduate Degree |
| Technion-Israel Institute of Technology | Masters Business Admin |
| New York University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Entreprise privées | 9 |
|---|---|
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Starlet Derma Ltd.
Starlet Derma Ltd. Pharmaceuticals: MajorHealth Technology Starlet Derma Ltd. develops a novel marine extracted microinjection system for Intra-dermal penetration. It provides its services through its wholly owned subsidiary, NanoCyte Ltd. The firm's products are used for various cosmeceutical applications, such as acne treatments, whitening, pain relief, anti-aging treatments, and slimming treatments. The company was founded by Shimon Eckhouse, Chen Porat, and Amid Lotan in 2000 and is headquartered in Caesarea, Israel. | Health Technology |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
Integra Holdings Ltd.
Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Miscellaneous |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Finance |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Finance |
NanoCyte Ltd.
NanoCyte Ltd. Pharmaceuticals: MajorHealth Technology NanoCyte Ltd. develops transdermal drug delivery platform technology solutions. The firm offers cosmeceutical and pharmaceutical applications such as whitening, acne, anti-aging, and slimming treatment. The company was founded by Shimon Eckhouse and is headquartered in Zemach, Israel. | Health Technology |